1. Oral Antibiotics in Clinical Development for Community-Acquired Urinary Tract Infections

   • Balaji Veeraraghavan
   • Yamuna Devi Bakthavatchalam
   • Rani Diana Sahni

   Commentary Open access 06 August 2021 Pages: 1815 - 1835

2. Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

   • Matteo Bassetti
   • Daniele Roberto Giacobbe
   • the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

   Guidelines Open access 30 July 2021 Pages: 1837 - 1885

3. Systematic Literature Review and Quantitative Analysis of Health Problems Associated with Sexually Transmitted Neisseria gonorrhoeae Infection

   • Jane Whelan
   • Jennifer Eeuwijk
   • Ekkehard Beck

   Review Open access 17 July 2021 Pages: 1887 - 1905

   

4. Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations

   • Fei Chen
   • Lanting Hao
   • Huiran Chen

   Review Open access 22 July 2021 Pages: 1907 - 1931

   

5. A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2

   • Ramesh Nathan
   • Imad Shawa
   • Gregory Huhn

   Review Open access 10 August 2021 Pages: 1933 - 1947

   

6. Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination

   • Lamine Soumahoro
   • Véronique Abitbol
   • Marco A. P. Safadi

   Review Open access 11 August 2021 Pages: 1949 - 1988

   

7. Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review

   • Alex Soriano
   • Yehuda Carmeli
   • Paurus Irani

   Review Open access 11 August 2021 Pages: 1989 - 2034

   

8. The Epidemiology of Invasive Meningococcal Disease in the Kingdom of Saudi Arabia: A Narrative Review with Updated Analysis

   • Selim Badur
   • Mona A. Al Dabbagh
   • Mansour Khalaf

   Review Open access 14 August 2021 Pages: 2035 - 2049

   

9. HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review

   • Rickesh Patel
   • Lee Evitt
   • Justin Koteff

   Review Open access 24 August 2021 Pages: 2051 - 2070

   

10. Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe

    • Denis Macina
    • Keith E. Evans

    Review Open access 26 August 2021 Pages: 2071 - 2118

11. A Systematic Review of Pneumococcal Carriage, Disease, Antimicrobial Resistance, and Vaccination in Egyptian Children Aged 18 Years and Younger

    • Ahmed El-Beleidy
    • Moustafa El-Saied
    • Hammam Haridy

    Review Open access 01 September 2021 Pages: 2119 - 2155

    

12. Current Stage in the Development of Klebsiella pneumoniae Vaccines

    • Lucas Assoni
    • Raquel Girardello
    • Michelle Darrieux

    Review Open access 02 September 2021 Pages: 2157 - 2175

    

13. Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists

    • Jacinda C. Abdul-Mutakabbir
    • Nicole C. Griffith
    • Zahra Kassamali Escobar

    Review Open access 14 October 2021 Pages: 2177 - 2202

14. Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

    • Alessio Aghemo
    • Yves Horsmans
    • Pietro Lampertico

    Original Research Open access 14 June 2021 Pages: 2203 - 2222

    

15. Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

    • Alessio Aghemo
    • Yves Horsmans
    • Pietro Lampertico

    Correction Open access 16 September 2021 Pages: 2223 - 2225

16. The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the Literature

    • Ili Margalit
    • Anat Yahav
    • Dafna Yahav

    Original Research Open access 20 July 2021 Pages: 2227 - 2246

    

17. Management and Microbiology of Perforated Appendicitis in Pediatric Patients: A 5-Year Retrospective Study

    • Alex S. Plattner
    • Jason G. Newland
    • Baddr A. Shakhsheer

    Original Research Open access 21 July 2021 Pages: 2247 - 2257

    

18. Efficacy of Peginterferon alfa-2b in Nucleoside Analogue Experienced Patients with Negative HBeAg and Low HBsAg: A Non-Randomized Clinical Trial

    • Jun Chen
    • Min Qi
    • Yan Huang

    Original Research Open access 25 July 2021 Pages: 2259 - 2270

    

19. Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India

    • Canna J. Ghia
    • Emily K. Horn
    • Matt D. Wasserman

    Original Research Open access 27 July 2021 Pages: 2271 - 2288

20. Correction to: Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India

    • Canna J. Ghia
    • Emily K. Horn
    • Matt D. Wasserman

    Correction Open access 08 September 2021 Pages: 2289 - 2289

21. Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

    • Mohammad Bosaeed
    • Ebrahim Mahmoud
    • Ahmad Alaskar

    Original Research Open access 28 July 2021 Pages: 2291 - 2307

    

22. Time Trend of the Sensitivity of the Pneumococcal Urinary Antigen Test for Diagnosing Pneumococcal Community-Acquired Pneumonia: An Analysis of 15-Year, Prospective Cohort Data

    • Akihiro Ito
    • Tadashi Ishida
    • Yasuyoshi Washio

    Original Research Open access 02 August 2021 Pages: 2309 - 2322

    

23. Analysis of the Efficacy and Safety of PEGylated Interferon-α2b Treatment in Inactive Hepatitis B Surface Antigen Carriers

    • Yan Huang
    • Min Qi
    • Ruochan Chen

    Original Research Open access 04 August 2021 Pages: 2323 - 2331

    

24. Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial

    • Konstantinos Tsiakos
    • Antonios Tsakiris
    • Evangelos J. Giamarellos-Bourboulis

    Original Research Open access 06 August 2021 Pages: 2333 - 2351

    

25. Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure

    • Yuichiro Shindo
    • Yasuhiro Kondoh
    • Yoshinori Hasegawa

    Original Research Open access 08 August 2021 Pages: 2353 - 2369

    

26. Multicenter Evaluation of a Fully Automated High-Throughput SARS-CoV-2 Antigen Immunoassay

    • Dominik Nörz
    • Flaminia Olearo
    • Marc Lütgehetmann

    Original Research Open access 09 August 2021 Pages: 2371 - 2379

    

27. Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2

    • Elena Riester
    • Mario Majchrzak
    • Christoph Niederhauser

    Original Research Open access 09 August 2021 Pages: 2381 - 2397

    

28. Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program

    • John E. Mazuski
    • Florian Wagenlehner
    • Margaret Tawadrous

    Original Research Open access 10 August 2021 Pages: 2399 - 2414

    

29. Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study

    • Lei Zha
    • Dayan Zhang
    • Boris Tefsen

    Original Research Open access 10 August 2021 Pages: 2415 - 2429

    

30. Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection

    • Yuying Chen
    • Da Huang
    • Weiming Yan

    Original Research Open access 13 August 2021 Pages: 2431 - 2446

    

31. Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis

    • Yuqing Cui
    • Yali Sun
    • Tongwen Sun

    Original Research Open access 13 August 2021 Pages: 2447 - 2463

    

32. Burden of Seasonal Influenza A and B in Panama from 2011 to 2017: An Observational Retrospective Database Study

    • Juan Miguel Pascale
    • Danilo Franco
    • Patricia Juliao

    Original Research Open access 23 August 2021 Pages: 2465 - 2478

    

33. Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern

    • Marco Falcone
    • Giusy Tiseo
    • Francesco Menichetti

    Original Research Open access 25 August 2021 Pages: 2479 - 2488

    

34. Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial

    • Masaharu Shinkai
    • Kenji Tsushima
    • Satoshi Iwata

    Original Research Open access 27 August 2021 Pages: 2489 - 2509

    

35. Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program

    • Oscar Salva
    • Pablo A. Doreski
    • Néstor H. García

    Original Research Open access 30 August 2021 Pages: 2511 - 2524

    

36. Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options

    • Danli Chen
    • Zhiping Qian
    • Jinjun Chen

    Original Research Open access 01 September 2021 Pages: 2525 - 2538

    

37. A New Electrochemiluminescence-Based Multiplex Assay for the Assessment of Human Antibody Responses to Bordetella pertussis Vaccines

    • Kucku Varghese
    • William Bartlett
    • Shekema Hodge

    Original Research Open access 02 September 2021 Pages: 2539 - 2561

    

38. Acute Gastroenteritis Morbidity and Mortality Trends Following Universal Rotavirus Vaccination in Children in Peru: Ecological Database Study with Time-Trend Analysis

    • Patricia Juliao
    • Adriana Guzman-Holst
    • Theresa J. Ochoa

    Original Research Open access 05 September 2021 Pages: 2563 - 2574

    

39. Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study

    • Johan Van Laethem
    • Stephanie Wuyts
    • Sabine D. Allard

    Original Research Open access 16 September 2021 Pages: 2575 - 2591

    

40. Incidence and Mortality Trends of Acute Gastroenteritis and Pneumococcal Disease in Children Following Universal Rotavirus and Pneumococcal Conjugate Vaccination in Ecuador

    • Patricia Juliao
    • Adriana Guzman-Holst
    • Carlos Torres

    Original Research Open access 21 September 2021 Pages: 2593 - 2610

    

41. Tolerability and Adherence of Antiretroviral Regimens Containing Long-Acting Fusion Inhibitor Albuvirtide for HIV Post-Exposure Prophylaxis: A Cohort Study in China

    • Jingmin Nie
    • Feng Sun
    • Yaokai Chen

    Original Research Open access 29 September 2021 Pages: 2611 - 2623

    

42. Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants

    • Johnna Perdrizet
    • Emily K. Horn
    • Anna Ong-Lim

    Original Research Open access 30 September 2021 Pages: 2625 - 2642

    

43. The Effect of Combination Therapy on Mortality and Adverse Events in Patients with Staphylococcus aureus Bacteraemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    • Chao Ye
    • Chunjiang Wang
    • Zhaohui Wang

    Original Research Open access 01 October 2021 Pages: 2643 - 2660

    

44. A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus

    • Shan-Chi Yu
    • Kuan-Yin Ko
    • Tsung-Lin Yang

    Original Research Open access 08 October 2021 Pages: 2661 - 2675

    

45. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

    • Silvia Gómez-Zorrilla
    • Federico Becerra-Aparicio
    • for the REIPI/GEIRAS-GEMARA SEIMC ITUBRAS-2 Group

    Original Research Open access 09 October 2021 Pages: 2677 - 2699

46. Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

    • Matt D. Wasserman
    • Johnna Perdrizet
    • Raymond A. Farkouh

    Original Research Open access 11 October 2021 Pages: 2701 - 2720

    

47. Ceftazidime–Avibactam-Based Versus Tigecycline-Based Regimen for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia in Critically Ill Patients

    • Ying Shi
    • Jing Hu
    • Xiangrong Zuo

    Original Research Open access 15 October 2021 Pages: 2721 - 2734

48. Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)

    • Aránzazu Sancho-López
    • Antonio F. Caballero-Bermejo
    • the SARTRE-Study Group

    Original Research Open access 17 October 2021 Pages: 2735 - 2748

    

49. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    • Andrea Gutiérrez-Villanueva
    • Patricia Muñoz
    • Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis infecciosa en España (GAMES)

    Brief Report Open access 26 July 2021 Pages: 2749 - 2764

    

50. Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals

    • Soumya Jaganathan
    • Francis Stieber
    • Jenny Howard

    Brief Report Open access 25 August 2021 Pages: 2765 - 2776